| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,670 | 24,358 | 20,627 | 25,730 | | Cost of Revenue | 19,316 | 17,176 | 14,825 | 19,127 | | | Gross Profit | 8,354 | 7,182 | 5,802 | 6,603 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,527 | 1,483 | 4,994 | 4,459 | | Non Recurring | (1,082) | 1,974 | (891) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,855 | 3,725 | 1,699 | 2,145 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,029) | 19 | 411 | (388) | | Earnings Before Interest And Taxes | 2,516 | 3,830 | 2,243 | 1,847 | | Interest Expense | 61 | 71 | 119 | 208 | | Income Before Tax | 2,455 | 3,760 | 2,125 | 1,639 | | Income Tax Expense | 944 | 695 | 460 | 260 | | Minority Interest | (9) | (1) | (21) | 96 | | | | Net Income From Continuing Ops | 3,334 | 3,064 | 1,644 | 1,475 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,946 | 3,064 | 1,644 | 1,475 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,946 | $3,064 | $1,644 | $1,475 |
|
0.01% Nasdaq 
0.1199 (1.96%) 
Income Statement
